Transscleral cyclophotocoagulation versus cyclocryotherapy in treatment of neovascular glaucoma: a retrospective analysis

Trabeculectomy With Mitomycin C Combined With Direct Cauterization of Peripheral Iris in the Management of Neovascular Glaucoma

“…Medical therapy and various types of surgical treatment modalities including laser and cryo cyclodestructive procedures, implantation of drainage tube devices and trabeculectomy with mitomycin C (MMC) or fluorouracil (5-FU) can be used in controlling intraocular pressure (IOP). [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18] Also, preoperative panretinal laser photocoagulation (PRP) increases surgical success by inhibiting neovascularization; however, it is sometimes difficult to perform because of the hazy ocular media. 3,[19][20][21] Trabeculectomy with MMC is an effective surgical method in reducing the IOP of the eyes with medical therapy-resistant NVG.…”

One-site Versus Two-site Endoscopic Cyclophotocoagulation

“…Previously developed methods targeting the CP, such as cyclocryotherapy and diode cycloablation, are procedures done without direct visualization of treated tissue and have been typically reserved for cases of endstage glaucoma after other medical and surgical modalities have failed to control IOP. [1][2][3] The experience with these less precise modalities has led to a degree of apprehension and skepticism about the use of ECP. Still, the use of ECP has increased with more cases performed earlier in the course of treatment.…”

Retinal vein occlusion management algorithm. Part 3. Neovascular complications

“…До эпохи приме-нения препаратов анти-VEGF-группы приоритет-ным способом лечения неоваскулярной глаукомы были оперативные вмешательства с использовани-ем клапанных дренажей типа Krupin и Ahmed [15][16][17]. Циклодеструктивные вмешательства чаще при-менялись на глазах с остаточными зрительными функциями, так как процедура трудно дозируема и имеет ряд серьезных осложнений: так, по данным некоторых авторов, частота развития субатрофии глазного яблока может достигать 1,5-8,6% [18][19][20][21][22]. Интраокулярное введение ингибиторов VEGF (ин-тракамеральное, интравитреальное) приводит к бы-строму регрессу неососудов переднего отрезка в те-чение первых 2-3 дней.…”